Rockefeller Capital Management L.P. Agenus Inc Transaction History

Rockefeller Capital Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.35 - $3.47 $2,350 - $3,470	-1,000 Reduced 20.0%	4,000 $9,000
Q3 2021 Nov 12, 2021	SELL	$4.98 - $6.63 $4,980 - $6,630	-1,000 Reduced 16.67%	5,000 $26,000
Q2 2021 Aug 10, 2021	SELL	$2.56 - $5.49 $7,680 - $16,470	-3,000 Reduced 33.33%	6,000 $32,000
Q3 2019 Nov 12, 2019	BUY	$2.17 - $3.14 $19,530 - $28,260	9,000 New	9,000 $23,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.